<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03233646</url>
  </required_header>
  <id_info>
    <org_study_id>Pro00082598</org_study_id>
    <nct_id>NCT03233646</nct_id>
  </id_info>
  <brief_title>OCTA in Mild Cognitive Impairment and Alzheimer's Disease</brief_title>
  <official_title>Evaluating the Retinal Microvasculature in Mild Cognitive Impairment and Alzheimer's Disease Using Optical Coherence Tomography Angiography</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Duke University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Duke University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>Yes</is_fda_regulated_device>
    <is_unapproved_device>No</is_unapproved_device>
    <is_ppsd>No</is_ppsd>
    <is_us_export>No</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study aims to develop and evaluate biomarkers using non-invasive optical coherence
      tomography angiography (OCTA) to assess the structure and function of the retinal
      microvasculature in persons with mild cognitive impairment (MCI) and Alzheimer's Disease (AD)
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Using a multidisciplinary approach, this study aims to yield new insight into the vascular
      pathophysiology of mild cognitive impairment (MCI) and Alzheimer's Disease (AD). The
      investigators propose to develop and evaluate biomarkers using non-invasive optical coherence
      tomography angiography (OCTA) to assess the structure and function of the retinal
      microvasculature in persons with MCI and AD.

      The investigators hypothesize that microvascular network alterations in the retina mirror and
      possibly precede changes in the cerebral microcirculation seen in MCI and AD. Using advanced
      image analysis, the investigators aim to evaluate markers of reduced capillary blood flow and
      non-perfusion in the superficial and deep retinal vascular plexuses and choriocapillaris
      imaged using OCTA, in a resolution not previously possible, that would complement already
      established retinal structural markers and increase their sensitivity and specificity in the
      early detection of MCI and AD.

      This study looks to provide a proof of concept for OCTA-based retinal microvascular
      biomarkers as an effective screening tool in cognitive aging.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">July 20, 2017</start_date>
  <completion_date type="Anticipated">July 2018</completion_date>
  <primary_completion_date type="Anticipated">July 2018</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Non-Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Screening</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Foveal avascular zone</measure>
    <time_frame>12 months</time_frame>
    <description>Differences in Foveal avascular zone size</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Vessel Density</measure>
    <time_frame>12 months</time_frame>
    <description>Differences in Superficial and Deep Capillary Plexus Vessel Density</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Choroidal Thickness</measure>
    <time_frame>12 months</time_frame>
    <description>Differences in subfoveal choroidal thickness between the two groups</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">200</enrollment>
  <condition>Alzheimer Disease</condition>
  <condition>Mild Cognitive Impairment</condition>
  <condition>Retinal Vascular</condition>
  <arm_group>
    <arm_group_label>Case</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>100 patients with MCI and/or AD</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Controls</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Controls will be recruited from the relatives/attendants of the patients , or will be patients themselves, and will not have a diagnosis of MCI/AD.</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Retinal Imaging</intervention_name>
    <description>Non-invasive OCTA scan of retina</description>
    <arm_group_label>Case</arm_group_label>
    <arm_group_label>Controls</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patients with neurodegenerative disease (MCI and AD)

          -  Age-gender-race-matched controls.

        Exclusion Criteria:

          -  History of known or suspected diagnosis of non-AD

          -  Associated dementia

          -  Diabetes mellitus

          -  Inability to cooperate with or complete testing

          -  Evidence of glaucoma

          -  Macular degeneration

          -  Other neurologic or age-related ocular conditions that would impact OCTA segmentation.
             -Eyes that have had intraocular surgery, other than cataract surgery, will be excluded

          -  If two eyes satisfy the inclusion criteria, both eyes will be included in the study.
             If one eye satisfies the inclusion criteria, the eye that qualifies will be included
             in the study.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Dilraj Grewal, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Duke University</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Sharon Fekrat, MD</last_name>
    <role>Study Director</role>
    <affiliation>Duke University</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Dilraj Grewal, MD</last_name>
    <phone>919-684-4458</phone>
    <email>dilraj.grewal@duke.edu</email>
  </overall_contact>
  <location>
    <facility>
      <name>Duke University Medical Center</name>
      <address>
        <city>Durham</city>
        <state>North Carolina</state>
        <zip>27705</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Dilraj Grewal, MD</last_name>
      <phone>919-684-4458</phone>
      <email>dilraj.grewal@duke.edu</email>
    </contact>
    <investigator>
      <last_name>Sharon Fekrat, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>James Burke, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>July 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>July 26, 2017</study_first_submitted>
  <study_first_submitted_qc>July 26, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">July 28, 2017</study_first_posted>
  <last_update_submitted>July 26, 2017</last_update_submitted>
  <last_update_submitted_qc>July 26, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">July 28, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>OCT angiography</keyword>
  <keyword>Optical Coherence Tomography</keyword>
  <keyword>Vessel Density</keyword>
  <keyword>Superficial Capillary Plexus</keyword>
  <keyword>retinal microvasculature</keyword>
  <keyword>OCTA</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Alzheimer Disease</mesh_term>
    <mesh_term>Cognitive Dysfunction</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

